際際滷

際際滷Share a Scribd company logo
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Signals of non-acceptable quality
Voluntary activation
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Voluntary Activation
Acceptable spikes are based only on the parallel rising lines.
Interpotential vs. inter-discharge interval without correlation.
Cannot be used for the peak algoritm
Orbicularis Oculi - 50 袖V / 0.5 ms
IPI (袖s) vs response number IPI (袖s) vs rIDI (ms)
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Extensor Digitorum - 0.2 mV / 0.5 ms
Trigger
MCD = 19 袖s
Trigger here, reveals that the rising
segments are not paralell
cSFAP
Not acceptable signals
Voluntary Activation
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Extensor Digitorum - 0.3 mV / 0.3 ms
Trigger
Measuring jitter accurately is impossible when there is significant
variation in amplitude.
cSFAPs
Cannot be used for jitter estimation
Voluntary Activation
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Extensor Digitorum - 3 mV / 0.8 ms
Extensor Digitorum - 1 mV / 0.8 ms
*
Trigger
MCD = 40 袖s
cSFAPs
The first spike cannot be used for jitter estimation
Voluntary Activation
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Extensor Digitorum - 50 袖V / 0.5 ms
Trigger
cSFAPs
The second spike cannot be used for jitter estimation as it represents acitivity from different fibers
Voluntary Activation
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
cSFAPs
Voluntary Activation
The spikes to the left are non-acceptable.
The first three spikes to the right are acceptable, but not the last one.
Extensor Digitorum  0.1 mV / 0.5 ms
Trigger
MCD = 16 袖s
**
Extensor Digitorum  0.5 mV / 0.5 ms
Trigger (by level)
*
MCD = 108 袖s
 signal not acceptable since the triggering spike is a summation
 ** first three spikes OK but not the last one
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Damaged fiber
The second signal is after discharge from the first fiber, likely generated
by a irritation of the muscle membrane
Not used for jitter assessment
Voluntary Activation
MCD = 77 袖s (FALSE)
Extensor Digitorum - 200 袖V / 1 ms
息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg
Triangular after-potential ,Damaged fiber
The second signal is after- discharge from the first fiber, likely
generated by a irritation of the muscle membrane
Not used for jitter assessment
Voluntary Activation
MCD = 77 袖s (FALSE)
Extensor Digitorum - 200 袖V / 1 ms

More Related Content

More from Erik St奪lberg (20)

SFEMG Signal Atlas - Extensive - Stimulated
SFEMG Signal Atlas - Extensive - StimulatedSFEMG Signal Atlas - Extensive - Stimulated
SFEMG Signal Atlas - Extensive - Stimulated
Erik St奪lberg
SFEMG Signal Atlas - Highlights - Stimulated - FWaves, Extra Discharges
SFEMG Signal Atlas - Highlights - Stimulated -  FWaves, Extra DischargesSFEMG Signal Atlas - Highlights - Stimulated -  FWaves, Extra Discharges
SFEMG Signal Atlas - Highlights - Stimulated - FWaves, Extra Discharges
Erik St奪lberg
Single Fiber EMG (SFEMG) Signal Atlas - Introduction
Single Fiber EMG (SFEMG) Signal Atlas - IntroductionSingle Fiber EMG (SFEMG) Signal Atlas - Introduction
Single Fiber EMG (SFEMG) Signal Atlas - Introduction
Erik St奪lberg
QUIZ RNS
QUIZ RNSQUIZ RNS
QUIZ RNS
Erik St奪lberg
QUIZ SFEMG
QUIZ SFEMGQUIZ SFEMG
QUIZ SFEMG
Erik St奪lberg
NCS special
NCS specialNCS special
NCS special
Erik St奪lberg
NCS routine
NCS routineNCS routine
NCS routine
Erik St奪lberg
EMG special
EMG specialEMG special
EMG special
Erik St奪lberg
EMG routine
EMG routineEMG routine
EMG routine
Erik St奪lberg
RNS
RNSRNS
RNS
Erik St奪lberg
EMG NCS Scoring
EMG NCS ScoringEMG NCS Scoring
EMG NCS Scoring
Erik St奪lberg
32b. Conc Jitter
32b. Conc Jitter32b. Conc Jitter
32b. Conc Jitter
Erik St奪lberg
20. Late resp F H
20. Late resp F H20. Late resp F H
20. Late resp F H
Erik St奪lberg
11. Myopati
11. Myopati11. Myopati
11. Myopati
Erik St奪lberg
TM
TMTM
TM
Erik St奪lberg
Macro EMG
Macro EMGMacro EMG
Macro EMG
Erik St奪lberg
History SFEMG
History SFEMGHistory SFEMG
History SFEMG
Erik St奪lberg
EDX Facialis
EDX FacialisEDX Facialis
EDX Facialis
Erik St奪lberg
Decrement 171026
Decrement 171026Decrement 171026
Decrement 171026
Erik St奪lberg
ALS m Polio MMN
ALS m Polio MMNALS m Polio MMN
ALS m Polio MMN
Erik St奪lberg

Recently uploaded (20)

ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Performance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhusPerformance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhus
SmitaDeshkar
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
Pharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing classPharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing class
koxoyav221
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025
Badalona Serveis Assistencials
Asthma: Causes, Types, Symptoms & Management A Comprehensive Overview
Asthma: Causes, Types, Symptoms & Management  A Comprehensive OverviewAsthma: Causes, Types, Symptoms & Management  A Comprehensive Overview
Asthma: Causes, Types, Symptoms & Management A Comprehensive Overview
Dr Aman Suresh Tharayil
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause SymptomsMacafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Supplement
protocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Productsprotocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Products
alokksharma18
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptxPARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
DrDivitasaxena1
X-Ray-Generators-and-Transformers final.pdf
X-Ray-Generators-and-Transformers  final.pdfX-Ray-Generators-and-Transformers  final.pdf
X-Ray-Generators-and-Transformers final.pdf
Mohd Faraz
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Performance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhusPerformance of molecular and serologic tests for the diagnosis of scrub typhus
Performance of molecular and serologic tests for the diagnosis of scrub typhus
SmitaDeshkar
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
Pharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing classPharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing class
koxoyav221
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Multimodal Approaches to Clitoral Augmentation for FGM (PRP _ filler)"
Rehab Aboshama
Asthma: Causes, Types, Symptoms & Management A Comprehensive Overview
Asthma: Causes, Types, Symptoms & Management  A Comprehensive OverviewAsthma: Causes, Types, Symptoms & Management  A Comprehensive Overview
Asthma: Causes, Types, Symptoms & Management A Comprehensive Overview
Dr Aman Suresh Tharayil
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause SymptomsMacafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Supplement
protocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Productsprotocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Products
alokksharma18
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
Flag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptxFlag Screening in Physiotherapy Examination.pptx
Flag Screening in Physiotherapy Examination.pptx
BALAJI SOMA
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptxPARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
DrDivitasaxena1
X-Ray-Generators-and-Transformers final.pdf
X-Ray-Generators-and-Transformers  final.pdfX-Ray-Generators-and-Transformers  final.pdf
X-Ray-Generators-and-Transformers final.pdf
Mohd Faraz

SFEMG Signal Atlas - Highlights - Voluntary - Bad Signals

  • 1. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Signals of non-acceptable quality Voluntary activation
  • 2. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Voluntary Activation Acceptable spikes are based only on the parallel rising lines. Interpotential vs. inter-discharge interval without correlation. Cannot be used for the peak algoritm Orbicularis Oculi - 50 袖V / 0.5 ms IPI (袖s) vs response number IPI (袖s) vs rIDI (ms)
  • 3. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Extensor Digitorum - 0.2 mV / 0.5 ms Trigger MCD = 19 袖s Trigger here, reveals that the rising segments are not paralell cSFAP Not acceptable signals Voluntary Activation
  • 4. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Extensor Digitorum - 0.3 mV / 0.3 ms Trigger Measuring jitter accurately is impossible when there is significant variation in amplitude. cSFAPs Cannot be used for jitter estimation Voluntary Activation
  • 5. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Extensor Digitorum - 3 mV / 0.8 ms Extensor Digitorum - 1 mV / 0.8 ms * Trigger MCD = 40 袖s cSFAPs The first spike cannot be used for jitter estimation Voluntary Activation
  • 6. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Extensor Digitorum - 50 袖V / 0.5 ms Trigger cSFAPs The second spike cannot be used for jitter estimation as it represents acitivity from different fibers Voluntary Activation
  • 7. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg cSFAPs Voluntary Activation The spikes to the left are non-acceptable. The first three spikes to the right are acceptable, but not the last one. Extensor Digitorum 0.1 mV / 0.5 ms Trigger MCD = 16 袖s ** Extensor Digitorum 0.5 mV / 0.5 ms Trigger (by level) * MCD = 108 袖s signal not acceptable since the triggering spike is a summation ** first three spikes OK but not the last one
  • 8. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Damaged fiber The second signal is after discharge from the first fiber, likely generated by a irritation of the muscle membrane Not used for jitter assessment Voluntary Activation MCD = 77 袖s (FALSE) Extensor Digitorum - 200 袖V / 1 ms
  • 9. 息2024 J.A. Kouyoumdjian, D.B. Sanders, E.V. St奪lberg Triangular after-potential ,Damaged fiber The second signal is after- discharge from the first fiber, likely generated by a irritation of the muscle membrane Not used for jitter assessment Voluntary Activation MCD = 77 袖s (FALSE) Extensor Digitorum - 200 袖V / 1 ms

Editor's Notes